Free certificates of participation are available upon successful completion of a brief knowledge quiz at: https://www.classmarker.com/online-test/start/?quiz=yqt58b6db9137142
Published: 03/01/2017
Richard Frye, M.D., Ph.D. is the Director of Autism Research and Associate Professor of Pediatrics at The University of Arkansas for Medical Sciences. He specializes in pediatric neurology disorders, including learning disabilities and dyslexia, autism and developmental delay, speech and language delay, attention deficit, tics and Tourette’s syndrome, sleep disorders, and epileptic encephalopathy. Dr. Frye is board certified in General Pediatrics and in Neurology with special competency in Child Neurology. He has also completed Fellowships in Behavioral Neurology and Psychology. Dr. Frye has been funded by the National Institutes of Health to study brain reorganization in individuals with neurodevelopmental disorders and currently has grants to study mitochondrial disease in autism and the metabolic effects of tetrahydrobiopterin treatment in children with neurodevelopmental disorders.
Biomarkers start telling us a story: Autism pathophysiology revisited
Learn about emerging research on biomarkers and autism from a recent ARI Research Grant recipient. This is a joint presentation with the World Autism Organisation. The presentation by Dr.
The Low-Hanging Fruit: Exploring Monogenic Syndromes with Elevated Rates of Autism
Learn research updates on how genes associated with autism are functioning in the brain and how changes in these genes are linked to characteristics of autism and other conditions.
Prenatal exposure to cannabis may increase likelihood of autism
Cannabis use during pregnancy may alter placental and fetal DNA methylation (the process of turning genes “on” and “off”) in ways that increase the likelihood of autism spectrum disorder (ASD) or
Behavioral and Brain Signatures of Autism in Females
Kaustubh Supekar, Ph.D., examines recent findings about gender/sex differences in autism phenotypes and brain organization. He highlights the underrepresentation of females in autism and underscores the need for a large-scale science approach. The
Alzheimer’s drug appears to benefit adult men with fragile X
A drug intended to help people with Alzheimer’s disease may also be beneficial for individuals with fragile X syndrome, according to a new study. Fragile X syndrome is the most common known
“Genetic wrinkles” in DNA may explain some cases of ASD
Researchers in Canada report that expanded tandem DNA repeats—what they dub “genetic wrinkles” in DNA—may play a significant role in autism spectrum disorders (ASD). Stephen Scherer and his team, including first author